Want to join the conversation?
Janssen-Cilag International, a $JNJ company, said a final, following this CHMP positive opinion, decision from the European Commission is expected later this year. Janssen is now seeking approval for ustekinumab for the treatment of adult patients with moderately to severely active Crohn's disease in the U.S.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?